Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
8 Cards in this Set
- Front
- Back
|
Etomidate (Amidate)
Classification : |
Non-narcotic, Non-benzodazepine sedative hypnotic, anesthic
|
|
|
Etomidate (Amidate)
Therapeutic Effects: |
*Ultrashort acting, short duration drug that provides deep CNS sedation, muscle relaxation, and some anterograde amnesia
*Believed to decrease the activity of the RSA (Reticular Activating System) in the brainstem |
|
|
Etomidate (Amidate)
indications : |
*Conscious sedation prior to uncomfortable procedures
*Sedation-Assisted Intubation (SAI) |
|
|
Etomidate (Amidate)
Contraindications: |
Hypersensitivity to the drug
|
|
|
Etomidate (Amidate)
Side Effects:(Cardio) |
tachycardia, bradycardia, hypertension, hypotension
|
|
|
Etomidate (Amidate)
Side Effects: (Repiratory) |
hypoventilation, respiratory arrest
|
|
|
Etomidate (Amidate)
Side Effects:(other) |
nausea, vomiting, pain at injestion site, myclonus
|
|
|
Etomidate (Amidate)
Administration: |
*0.2-0.6mg/kg SIVP over 30-60 seconds
*PA Statewide Protocol for SAI *15-30mg (0.3mg/Kg)- Dose should not exceed 30mg |
